Skip to main content

Advertisement

Table 2 Distribution of types of aneuploidies

From: Embryos derived from donor or patient oocytes are not different for in vitro fertilization outcomes when PGT allows euploid embryo selection: a retrospective study

 Patient/donor oocytesPatient oocytesDonor oocytes
Age range≥ 18≥ 18≤ 2918–32
Total embryos30382186172852
Abnormal embryos1351 (44.5%)1113 (50.9%)46 (26.7%)238 (27.9%)
Monosomy381 (28.2%)283 (25.4%)15 (32.6%)98 (41.2%)*
Trisomy346 (25.6%)282 (25.3%)13 (28.3%)64 (26.9%)
Dual302 (22.4%)266 (23.9%)11 (23.9%)36 (15.1%)*
Multiple322 (23.8%)a282 (25.3%)b7 (15.2%)c40 (16.8%)d,*
  1. *Indicates a significant difference (p < 0.05, chi-2 test) in the rate of chromosome abnormalities between embryos from patient oocytes and donor oocytes. ** indicates a significant difference (p < 0.05, chi-2 test) in the rate of chromosome abnormalities between embryos from patient oocytes and donor oocytes
  2. aTwenty-six embryos had completely abnormal chromosomal profiles
  3. bTwenty-two embryos had completely abnormal chromosomal profiles
  4. cZero embryos had completely abnormal chromosomal profiles
  5. dFour embryos had completely abnormal chromosomal profiles